Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
16.44
+0.36 (2.24%)
At close: Mar 4, 2026, 4:00 PM EST
16.44
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:12 PM EST
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.53 billion as of March 4, 2026. Its market cap has increased by 105.65% in one year.
Market Cap
2.53B
Enterprise Value
2.56B
1-Year Change
105.65%
Ranking
Category
Stock Price
$16.44
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.53B, a decrease of -46.98%. That is a compound annual growth rate of -9.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 2.48B | -0.13% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.70B |
| Travere Therapeutics | 2.61B |
| Apellis Pharmaceuticals | 2.58B |
| Wave Life Sciences | 2.53B |
| Disc Medicine | 2.46B |
| Dyne Therapeutics | 2.41B |
| Dianthus Therapeutics | 2.40B |
| Immunome | 2.38B |